Ronnie Yeager
Company: Abbvie
Job title: Project Director, Emerging Therapeutic Platforms
Seminars:
Chair’s Closing Remarks 3:15 pm
day: Conference Day 2
Optimizing Non-Clinical Safety Strategies for Use of NHPs: Facilitating Internal Decision Making and Regulatory Acceptance 3:30 pm
Refining platform toxicity study designs due to limited availability of NHPs Leveraging internal and external information to maximize data outputs to support Go/No Go decisions and select/advance candidate ADCs toward GLP toxicity Read more
day: Conference Day 1
Chair’s Opening Remarks 8:50 am
day: Conference Day 1
Chair’s Opening Remarks 9:50 am
day: Conference Day 2